期刊文献+

N-三甲基壳聚糖包衣阿霉素脂质体与普通脂质体的抗肿瘤活性比较 被引量:1

Comparison of the anti-tumour activity between N-trimethyl chitosan-coated adriamycin liposomes and regular adriamycin liposomes
原文传递
导出
摘要 目的:比较N-三甲基壳聚糖(TMC)包衣的盐酸阿霉素(ADM)脂质体与普通ADM脂质体的抗肿瘤活性。方法:采用硫酸铵梯度法制备ADM脂质体,以不同取代度的TMC进行包衣,采用动物移植性肿瘤实验法,用小鼠H22肝癌细胞接种于小鼠右侧腋下皮下形成实体瘤,考察TMC包衣ADM脂质体和普通脂质体给药后对实体瘤的瘤重抑制率。结果:TMC60、TMC40、TMC20包衣ADM脂质体对小鼠H22肝癌移植瘤的抑瘤率分别为64.3%,57.0%和54.8%,显著高于ADM脂质体组和游离ADM组(36.4%、42.7%)(P<0.05)。结论:TMC包衣ADM脂质体具有较好的抗肿瘤活性。 OBJECTIVE To comparison of the anti tumour activity between N-trimethyl chitosan (TMC)-coated adriamycin (ADM) liposomes and regular ADM liposomes. METHODS ADM liposomes were prepared by ammonium sulphate gradient method and coated by TMC with different degree of quarternization (DQ). The animal model of implantation of solid tumor was applied to evaluate the anti tumor effect of TMC coated ADM liposomes and regular ones by subcutaneous injection of murine hepatoma cells (H22) into the right limb armpit of mice. RESULTS The inhibitory rate on tumor of TMC60, TMC 40 and TMC211 coated ADM liposomes was 64. 3 % ,57. 0% and 54. 8%, respectively, which were remarkably higher than those of the regular ADM liposomes and free ADM (36.4% ,42.7% ) (P〈0.05). CONCLUSION TMC coated ADM liposomes have better anti-tumor effect compared with regular ADM liposomes.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2011年第2期110-113,共4页 Chinese Journal of Hospital Pharmacy
关键词 N-三甲基壳聚糖 阿霉素 脂质体 H22肝癌 肿瘤抑制率 N trimethyl chitosan adriamycin liposomes H22 hepatocarcinoma inhibitory rate on tumor
  • 相关文献

参考文献8

  • 1Strieth S, Eichhorn ME. Sauer B, et al. Neovascular tgreting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature [J].Int J Cancer, 2004,110:117- 124.
  • 2Sandri G, Rossi S. Bonferoni MC, et al. Buccal penetration enhancement properties of N trimethyl chitosan: Influence of quaternization deggre on absorption of a high molecular weight molecule[J]. International Journal of Pharmaceutics, 2005, 297,146- 155.
  • 3Jonker C, Hamman JH, Kotze AF. Intestinal paracellular permeation enhancement with quaternised chitosan: in situ and in vitro evalution[J].Int J Pharm, 2002,238,205-213.
  • 4Haran G, Cohen R, Bar I.K,et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable en trapment of amphipathic weak base[J]. Biochim Biophys Acta,1993,1151:201-215.
  • 5魏农农,陆彬.结肠定位壳聚糖包衣氟尿嘧啶脂质体的制备、形态与体外释放[J].药学学报,2003,38(1):53-56. 被引量:50
  • 6Dass CR. Improving anti angiogenic therapy via selective delivery cationic liposomes to tumor vasculature [J]. Int J Pham. 2003,267: 1-12.
  • 7赵惟,马会利,齐宪荣.靶向肿瘤新生血管的阿霉素阳离子脂质体的体外研究[J].药学学报,2007,42(9):982-988. 被引量:10
  • 8Schmitt Sody M, Strieth S, Krasnici S, et al. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy[J].Clin Cancer Res, 2003,9: 2335-2341.

二级参考文献31

  • 1Harrington KJ, Rowlinson-Busza G, Syrigos KN. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies [J]. Br J Cancer, 2000,83(2):232-238.
  • 2Sihorkar V, Vyas SP. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization [J]. J Pharm Sci, 2001,4(2):138-158.
  • 3Budai M, Szogyi M. Liposomes as drug carrier systems. Preparation, classification and therapeutic advantages of liposomes [J]. Acta Pharm Hung, 2001,71(1):114-118.
  • 4Edwards C. Physiology of the colorectal barrier [J]. Adv Drug Deliv Rev, 1997,28:173-190.
  • 5Roger CC. New Liposomes: a Practice Approach [M]. Oxford: Oxford University Press, 1994.108-109.
  • 6Schreiber AB, Haimovich J. Quantitative fluorometric assay for detection and characterization of Fc receptor [J]. Methods Enzymol, 1983,93:147-155.
  • 7Grcic FJ, Basnet S. Mucoadhesive chitosan-coated liposomes:characteristics and stability [J]. J Microencapsul, 2001,18(1):3-12.
  • 8Lamprecht A, Schfer U, Lehr CM. Structural analysis of microparticles by confocal laser scanning microscopy [J]. AAPS Pharm Sci Tech, 2000,1(3):article 17.
  • 9Lamprecht A, Schfer U, Lehr CM. Characterization of microcapsules by confocal laser scanning microscopy: structure, capsule wall composition and encapsulation rate [J]. Eur J Pharm Biopharm, 2000,49(1):1-9.
  • 10Henriken I, Smistad G, Karsen J. Interaction between liposomes and chitosan [J]. Int J Pharm, 1994,101:227-236.

共引文献56

同被引文献20

  • 1Li CL, Cui JX, Wang CX, et al. Lipid composition and graf- ted PEG affect in vivo activity of liposomal mitoxantrone [J]. Int J Pharm, 2008, 362(1-2): 60-66.
  • 2Koeller J, Eble M. Mitoxantrone: a novel anthracycline deriv- ative [J]. Clin Pharm, 1988, 7(8): 574-581.
  • 3Wiseman LR, Spencer CM. Mitoxantrone: A review of its pharmacology and clinical efcacy in the management of hor- mone-resistant advanced prostate cancer [J ]. Drugs Aging, 1997, 10(6) : 473-485.
  • 4Seiter, K. Toxicity of the topoisomerase II inhibitors [J]. Ex- pert Opin Drug Saf, 2005, 4: 219-234.
  • 5Cocco E, Marrosu MG. The current role of mitoxantrone in the treatment of multiple sclerosis [J]. Expert Rev Neuroth- er, 2014, 14(6): 607-616.
  • 6Yang ZZ, Li JQ, Wang ZZ, et al. Tumor-targeting dual pep- tides-modified cationic liposomes for delivery of siRNA and do- cetaxel to gliomas[J]. Biomaterials, 2014, 35(19): 5226- 5239.
  • 7Sarker SR, Hokama R, Takeoka S. Intracellular delivery of u- niversal proteins using a lysine headgroup containing cationic liposomes: Deeiphering the uptake mechanism [J ]. MolPharm. , 2014, 11(1): 164-174.
  • 8Zhuang Y, Ma Y, Wang C, et al. PEGylated cationic lipo- somes robustly augment vaccine-induced immune responses: Role of lymphatie trafficking and biodistribution [J]. J Control Release, 2012, 159(1): 135-142.
  • 9Strieth S, Dunau C, Michaelis U, et al. Phase Ⅰ/Ⅱ clinical study on safety and antivascular effects of paclitaxel encapsula- ted in cationic liposomes for targeted therapy in advanced head and neck cancer [J]. Head Neck, 2014, 36(7) : 976-984.
  • 10Hongtao LV, Zhang SB, Wang B, et al. Toxicity of cationic lipids and cationic polymers in gene delivery [J]. J Control Re- lease, 2006, 114(1): 100-109.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部